HippoFi 43a.webp

Dr. Gail Naughton, world-renowned authority on the multi-billion dollar regenerative medicine market, joins HippoFi as Head of Regenerative Therapeutics and Commercialization

 

Scientist, inventor, business expert and holder of more than 140 patents will advance PUR Biologics’ regenerative therapeutic patent portfolio to address unmet needs in the $200 billion osteoarthritis, pain and cartilage and spine regeneration markets.

IRVINE CA., November 7, 2023 – OrthoSpineNews HippoFi, Inc. (OTCPK: ORHB) is proud to announce the appointment of the world’s foremost authority and pioneer in regenerative medicine, Gail Naughton, MBA, Ph.D, as the “Head of Regenerative Therapeutics and Commercialization.”

Recognized worldwide, Dr. Naughton was awarded the 27th annual National Inventor of the Year by the Intellectual Property Owners Association in honor of her groundbreaking work in tissue engineering and regenerative medicine. Dr. Naughton has been a driving force in regenerative medicine for more than 35 years and, as founder of Advanced Tissue Sciences and Histogen, has a proven track record in monetizing important cell-based therapies and bioengineered tissue technologies. Although it is known for taking four products from concept, through FDA approval, to market launch; and taken two companies to a NASDAQ stock exchange listing, she has had broad success in commercializing major brands that are still widely sold today by establishing partnerships and strategic business alliances with several industry giants, including: NYSE Company Allergan (recently purchased by AbbVie for $63B), NYSE company Smith & Nephew, NYSE company Medtronic, and Inamed Corporation (also owned by AbbVie).

“I am thrilled and honored to join the visionary HippoFi team and work together to transform healthcare by developing and commercializing life-changing regenerative medicine solutions for unmet medical needs,” said Gail Naughton, MBA, Ph.D – Head of Regenerative Therapeutics and Commercialization.

Dr. Naughton has served on the board of directors of several public and private companies since 1988. She currently serves as chair of the board of directors of the La Jolla Institute, executive chair of BioHIP, a member of the boards of NASDAQ, Therapeutics MD, and NYSE company CelSci, and serves on the boards of International Business and Fowler College of Business at SDSU. In addition to serving for eleven years on the board of the Toronto-based, publicly funded Center for the Commercialization of Regenerative Medicine (CCRM), she also served for several years on the bioengineering advisory board of John Hopkins, UCSD, MIT and Georgia Tech. Dr. Naughton served as dean of the College of Business Administration at SDSU from 2002 to 2011 and received her Ph.D. and MS from NYU Medical Center and an MBA from UCLA.

“Dr. Naughton is a globally recognized, accomplished entrepreneur with many proven track records, visionary talent and unparalleled experience that will be extremely valuable to HippoFi’s continued growth and success,” said CJ Wiggins, MBA – Founder, Executive Chairman and CEO of HippoFi. “As a pioneer in our industry, adding her expertise to our experienced team not only helps us quickly commercialize and monetize our patented technologies, but also validates the tremendous market value of our patent portfolio and strengthens HippoFi as a leader in the market for regenerative therapies. ”

About PUR Biologics
PUR Biologics, a wholly owned subsidiary of HippoFi, Inc. (OTCPK: ORHB), is a leading biologics company committed to supporting surgeons and hospitals in providing the best care to their patients. PUR Biologics’ full line of biological products currently includes: advanced allografts and demineralized extracellular matrices (dECM), innovative synthetic solutions, cellular-derived tissues and a future of next-generation regenerative stem cell and growth factor-driven therapies for the treatment of osteoarthritis and cartilage regeneration.

About HippoFi, Inc.
HippoFi, Inc. delivers its breakthrough healthcare innovations through an extensive sales channel network while deploying first-to-market solutions in the multi-billion dollar biotech, fintech and artificial intelligence (AI) markets. HippoFi consists of three segments: Regenerative Therapeutics, Digital Payments and AI, which use the same customer channels to commercialize solutions, increase revenue and improve patient outcomes.

HippoFi, Inc. is publicly traded under the symbol: ORHB and is headquartered in Irvine, California. For more information, please visit: www.HippoFi.com and www.PURbiologics.com.

Contact
HippoFi, Inc.
949-323-2330
info@hippofi.com

Source link

Similar Posts

  • Paragon 28 Announces New $150 Million Credit Facility to Replace Existing $90 Million Credit Facility

      ENGLEWOOD, CO, November 7, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company focused exclusively on the foot and ankle orthopedic market, today announced that it has received a new $150 million credit facility from Ares Capital Corporation (“the Facility”) to replace the existing $90 million senior credit…

  • Sports managers need sports trainers for a better heat policy

      Exercise-induced heat illness: policy adoption and influence on contextual factors reported by athletic administrators Scarneo-Miller SE, Adams WM, Coleman KA, Lopez RM. Sports Health. Mar 5, 2023: 19417381231155107. doi: 10.1177/19417381231155107. E-publishing prior to printing. PMID: 36872595. https://journals.sagepub.com/doi/10.1177/19417381231155107 Take home message Most high school athletic administrators reported having a written heat illness policy in place,…

  • |

    Knee pain after sex

    What if a common physical sensation is quietly shaping the quality of our most private moments? This discomfort can feel isolating. It may make us pull back from our partner. The American Osteopathic Association notes that about one-third of Americans live with joint issues that hinder daily activities. knee pain after sex This statistic reflects a wider reality. When our bodies signal distress, it often echoes in our shared life. The ache isn’t just physical. It can create an invisible barrier to intimacy. We believe understanding is the first step toward change. By exploring the reasons behind this discomfort, we can make smart adjustments. Small changes to our routine can have a big impact. Our goal is to help you move from frustration to solution. Let’s look at how to protect your physical connection and ensure your experiences remain fulfilling and joyful. Key Takeaways Joint discomfort during intimate moments is a common issue that affects emotional and physical connection. Nearly one-third of adults in the U.S. report joint-related problems that impact their daily quality of life. This physical barrier can lead to avoiding closeness, which may strain a relationship. Identifying the root cause of the discomfort is a crucial proactive step toward improvement. Simple adjustments to routines and positions can help maintain a healthy and satisfying sex life. Open communication with your partner about physical limits is essential for mutual comfort. Seeking professional guidance can provide tailored strategies for long-term relief and enjoyment. Understanding Knee Pain After Sex It’s a reality for many: seeking closeness, only to be met with a sharp, distracting sensation. This discomfort has specific roots. Knowing them helps us adapt and find relief. Common Causes and Triggers Physical intimacy involves movement and pressure. These actions can strain the joint if it’s already sensitive. A sudden twist or prolonged kneeling might be the direct trigger. Interestingly, gentle motion can be helpful. Maiken Jacobs, an orthopedic patient educator, notes that moving a joint through its range of motion can release endorphins. This is good for your condition. Acute vs. Chronic Pain Explained We must distinguish between two main types. Acute discomfort often results from sudden injuries, like a sprain. It comes on quickly and usually fades with time and care. Chronic issues stem from long-term conditions. Osteoarthritis is a common example. This ongoing pain affects mobility and daily comfort for many people. Identifying which type you’re experiencing is the first step toward smart management. It guides our approach to maintaining a fulfilling connection. Preparing for Intimacy with Knee Sensitivity A little preparation can transform our intimate moments from a source of worry into a space of comfort and connection. We focus on simple, proactive steps that address physical sensitivity head-on. The Role of Warm Baths and Epsom Salts Starting with a warm bath is a powerful ritual. Adding Epsom salt helps soothe muscles and promotes deep relaxation. Taking a warm Epsom salt bath before intimacy can proactively ease joint discomfort and help you relax. Maiken Jacobs, Orthopedic Patient Educator This practice isn’t just solitary self-care. Turning it into a shared, sensual experience with our partner helps us both unwind and set the right mood. preparing for intimacy with knee sensitivity Pre-medicating and Managing Stress Stress tightens our bodies and can heighten our perception of discomfort. Managing tension is therefore a vital part of our preparation. If we’re concerned about potential aches, seeking information from a doctor is wise. They can advise on the ideal timing for taking an anti-inflammatory to maintain comfort. Proactive planning, like using a heating pad beforehand, ensures our focus stays on connection. Preparation Method Primary Benefit Key Consideration Warm Epsom Salt Bath Soothes muscles & promotes relaxation Can be a shared ritual with a partner Consulting a Doctor Personalized timing for medication Provides expert guidance for safety Stress Management Reduces tension that worsens discomfort Includes deep breathing or meditation…

  • Antibiotics wreak havoc on athletic performance

      New research shows that by killing essential gut bacteria, antibiotics affect athletes’ motivation and endurance. The UC Riverside-led mouse study suggests that the microbiome is a big factor that differentiates athletes from couch potatoes. Other studies have examined how exercise influences the microbiome, but this study is one of the few to examine the…

  • International sales gain for PUR Biologics

      PUR Biologics’ robust distribution channels appear to be expanding sales worldwide October 24, 2023, Irvine, CA., / OrthoSpineNews / – Following a successful participation at the North American Spine Society (NASS) conference, healthcare technology company HippoFi, Inc. (OTC: ORHB) announced that its wholly owned subsidiary, PUR Biologics, has expanded its sales to include several…

  • Bone Biologics Announces Registered Direct Offering at Market Prices Under Nasdaq Rules

      BURLINGTON, Mass., Nov. 17, 2023–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiology products for the spine fusion markets, today announced that it has entered into a definitive agreement to issue and sell a aggregate of 1,139,063 shares of common stock at a purchase price of $0.64 per share in a registered direct…

Leave a Reply

Your email address will not be published. Required fields are marked *